上海纽脉医疗科技股份有限公司成立于2015年，是一家致力于经导管心脏瓣膜的研发和产业化的高端医疗器械企业，具备完整的自主研发、测试与生产能力，自成立以来已在中国申请170余项发明及实用新型专利申请。 纽脉医疗围绕心脏瓣膜置换及修复进行全面产品布局，提供国内领先的瓣膜介入治疗综合创新解决方案。公司自主研发多款产品获准进入创新医疗器械特别审查程序，即“绿色通道”，且多款产品已进入注册临床阶段。这些创新产品将简化心脏瓣膜置换手术过程，大幅降低治疗风险，惠及更多患者。 纽脉医疗立足于创新研发，集国内外科研院所、高校、医院、企业等多方力量和资源，形成产学研医协同的创新平台和人才培养基地——纽脉奇点TM技术创新中心，为临床和患者带来更多可以惠及大众的高端医疗器械，打造属于中国的、同步于国际水平的高端医疗器械企业，践行“创新造福生命”的使命。 Shanghai NewMed Medical Co., Ltd, established in 2015, is a high-tech medical device company that is dedicated to the R&D and industrialization of transcatheter heart valve, with a complete independent R&D, testing and production capacity. NewMed Medical has applied for more than 170 inventions and utility model patents in China since establishment. NewMed Medical has put together a comprehensive portfolio of artificial heart valve and transcatheter implantation system, and provides the leading comprehensive innovative solutions of valve interventional therapy. The National Medical Products Administration (“NMPA”) of China has recognized numbers of NewMed Medical’s independently developed products as innovative medical devices that are qualified for an expedited Special Review. Numbers of products have entered the registered clinical stage. These innovative products will benefit the public by simplifying the replacement surgery and reducing treatment risks. Based on innovative research and development, NewMed Medical sets up the mode of partnering up industry, academia, researchers, and clinicians to bring more high-tech medical devices for clinicians and patients that can benefit the public. And it has formed an innovation platform and talent training base——NewMed Jidian Innovation Center, by integrating multi strengths and resources of scientific research institutes, universities, hospitals, enterprises at home and abroad. NewMed Medical aims to build a Chinese high-tech medical device company and synchronizes with the international level, and make the vision of “Innovations Improve Life" come true.